Pyridinoline cross-links as markers for primary and secondary bone tumors

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 63, Issue 1, 2003, Pages 37-44

  Behrens, Peter ^a   Bruns, J ^b   Ullrich, K P ^b   Acil Y ^c   Gille, J ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c NONE

Author keywords

Cross links; Metastases; Primary malignant bone neoplasms

Indexed keywords

BIOLOGICAL MARKER; CREATININE; DEOXYPYRIDINOLINE; PYRIDINOLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; BONE TUMOR; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CROSS LINKING; DIET; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; SOFT TISSUE SARCOMA;

EID: 0346774830     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510310000475     Document Type: Article

References (29)

1. Engler H, Koeberle D, Thuerlimann B, Sen H-J, Riesen WF. Diagnostic and prognostic value of biochemical markers in malignant bone disease: a prospective study on the effect of bisphosphonate on pain intensity and progression of malignant bone disease. Clin Chem Lab Med 1998; 36: 879-85.
2. Açil Y, Mueller PK. Rapid method for the isolation of the mature collagen cross-links, hydroxylysylpyridinoline and lysylpyridinoline. J Chromatogr A 1994; 644: 183-8.
3. Eyre DR, Dickson IR, Van Ness KP. Collagen crosslinking in human bone and cartilage: age-related changes in the content of mature hydroxypyridinium residues. Biochem J 1988; 252: 495-500.
4. Eyre DR, Koob TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 1984; 137: 380-8.
5. Eyre DR, Paz MA, Gallop PM. Cross-linking in collagen and elastin. Ann Rev Biochem 1984; 53: 717-48.
6. Robins SP, Seibel MJ, McLaren A. Collagen markers in urine in human arthritis. In: Maroudas A, Kuettner ??, editors. Methods in cartilage research. London: Academic Press, 1990. p. 348-52.
7. Hata K, Miura M, Fukumoto S, Matsumoto T. Assay of serum pyridinoline: a potential marker for bone resorption. Clin Chimica Acta 1995; 235: 221-7.
8. Seibel MJ, Cosman F, Shen V, Ratcliffe A, Lindsay R. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1993: 8: 881-9.
9. Seibel MJ, Duncan A, Bobins SP. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989; 16: 964-70.
10. Robins SP, Duncan A. Pyridinium crosslinks of bone and their location in peptides isolated from rat femur. Biochim Biophys Acta 1987; 914: 233-9.
11. Açil Y, Brinkmann J, Notbohm H, Müller PK, Bätge B. Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP). Scand J Clin Lab Invest 1996; 56: 275-83.
12. Gerrits MI, Thijssen JHH, Rijn HJM. Determination of pyridinoline and deoxy-pyridinoline in urine, with special attention to retaining their stability. Clin Chem 1995; 41: 571-4.
13. Maemura M, Iino Y, Yokoe T, Takei H. Serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with metastatic breast cancer. Oncol Rep 2000; 7: 1333-8.
14. Garnero P, Shih W, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994; 6: 1693-700.
15. Robins SP, Woitge H, Hesley R, Seibel MJ. A direct enzyme linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994; 9: 1643-9.
16. Seibel MJ, Gartenberg F, Silverberg SJ, Ratcliffe A, Robins SP, Bilezikian J. Urinary hydroxypyridinium crosslinks of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 1992; 74: 481-6.
17. Seibel MJ, Ratcliffe A, Cosman F. Urinary hydroxypyridinium crosslinks of collagen are markers of bone resorption and estrogen efficacy in postmenopausal women. Transact Orthop Res Soc 1991; 16: 279.
18. Seibel MJ, Robins SP, Bilezikian JP. Urinary pyridinium crosslinks of collagen. Specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 1992; 3: 263-70.
19. Uebelhardt D, Schlemmer A, Johansen J. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocr 1991; 72: 367-73.
20. Shaarawy M, Hasan M. Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteporosis. Scand J Clin Lab Invest 2001; 61: 513-21.
21. Body JJ, Delmas PD. Urinary pyridinium crosslinks as markers of bone resorption in tumor-associated hypercalcemia. J Clin Endocrinol Metab 1992; 74: 471-5.
22. Coleman RE, Houston S, James I, Rodger A, Rubens RD, Leonard RCF, Ford J. Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease. Br J Cancer 1992; 65: 766-8.
23. Demers LM, Costa L, Chinchilli VM, Gaydos L, Curley E, Lipton A. Biochemical markers of bone turnover in patients with metastatic bone disease. Clin Chem 1995; 41: 1489-94.
24. Lipton A, Demers L, Daniloff Y, Curley E, Hamilton Ch, Harvey H, Witters L, Seaman J, Van de Giessen K, Seyedin S. Increased urinary excretion of pyridinium cross-links in cancer patients. Clin Chem 1993; 39: 614-618.
25. Paterson CR, Robins SP, Horobin JM, Preese PE, Cuschieri A. Pyridinium cross-links as markers of bone resorption in patients with breast cancer. Br J Cancer 1991; 64: 884-6.
26. Seregni E, Martinetti A, Ferrari L, Bombardieri E. Clinical utility of biochemical marker of bone remodelling in patients with bone metastases of solid tumors. Q J Nucl Med 2001; 45: 7-17.
27. Tamada T, Sone T, Tomomitsu T, Jo Y. Biochemical markers for the detection of bone metastasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy. J Bone Miner Metab 2001; 19: 45-51.
28. Schachar NS. An update on the nonoperative treatment of patients with metastatic bone disease. Clin Orthop Res 2001; 382: 75-81.
29. Rauch F, Schönau E, Woitge H, Remer T, Seibel MJ. Urinary excretion of hydrox-pyridinium crosslinks of collagen reflects skeletal growth velocity in normal children. Exp Clin Endocrinol 1994; 102: 94-7.